MEDLAB Middle East 2021 Brings World of Laboratory Medicine Together Under ‘United by Business’ Show Theme
|
By LabMedica International staff writers Posted on 21 Jun 2021 |

Illustration
The 2021 edition of Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, took place at the Dubai World Trade Centre from 21-24 June, bringing the global healthcare community together under the show theme of ‘United by Business’.
A host of countries, including the UK, Germany, Austria, Belgium, Israel, Korea, Poland, Spain and the US, participated in the event. A range of key laboratory and trade professionals from across the region attended the live and in-person event. It featured a range of keynote speeches and scientific lectures, industry briefings, product demonstrations and networking opportunities, as well as a series of pre-arranged one-to-one meetings, with an emphasis on creating lasting relationships.
Underscoring the confidence within the industry and the increased demand from laboratory professionals to participate in a physical event, several companies and health authorities exhibited at the event. These included the UAE Ministry for Health and Prevention, the College of American Pathologists, Abbott Laboratories, Horiba, Randox Laboratories, Euroimmun, BioVender Group, Seegene, Stago and Erba Group.
Similar to last year, before travel restrictions and country-wide lockdowns, the event attracted over 23,000 professional visitors from over 140 countries and over 3,800 delegates. A total of 14 country pavilions were present at the 2021 edition of the show. The event featured eight Continuing Medical Education (CME) conferences during the live and in-person event and as part of the show's online element. New to the 2021 conference program was a dedicated focus on COVID-19 which addressed the latest scientific findings on the virus and discussed its impact on health in the region.
These were complemented by returning accredited conferences: Laboratory Management, Clinical Chemistry, Clinical Microbiology, Histopathology, Molecular & Genomic Diagnostics, Haematology and Blood Transfusion. A series of medical speciality days have also been scheduled, with experts presenting the latest advancements in specific clinical specialties, including multi-omics, genetics, and stem cells. Medlab Middle East also hosted a range of dedicated online focus days until July 22 to allow participants to continue to do business as well as featured over 180 educational sessions to choose from. The online event platform for both Arab Health and Medlab Middle East was launched on 23 May and will remain available until 22 July.
A host of countries, including the UK, Germany, Austria, Belgium, Israel, Korea, Poland, Spain and the US, participated in the event. A range of key laboratory and trade professionals from across the region attended the live and in-person event. It featured a range of keynote speeches and scientific lectures, industry briefings, product demonstrations and networking opportunities, as well as a series of pre-arranged one-to-one meetings, with an emphasis on creating lasting relationships.
Underscoring the confidence within the industry and the increased demand from laboratory professionals to participate in a physical event, several companies and health authorities exhibited at the event. These included the UAE Ministry for Health and Prevention, the College of American Pathologists, Abbott Laboratories, Horiba, Randox Laboratories, Euroimmun, BioVender Group, Seegene, Stago and Erba Group.
Similar to last year, before travel restrictions and country-wide lockdowns, the event attracted over 23,000 professional visitors from over 140 countries and over 3,800 delegates. A total of 14 country pavilions were present at the 2021 edition of the show. The event featured eight Continuing Medical Education (CME) conferences during the live and in-person event and as part of the show's online element. New to the 2021 conference program was a dedicated focus on COVID-19 which addressed the latest scientific findings on the virus and discussed its impact on health in the region.
These were complemented by returning accredited conferences: Laboratory Management, Clinical Chemistry, Clinical Microbiology, Histopathology, Molecular & Genomic Diagnostics, Haematology and Blood Transfusion. A series of medical speciality days have also been scheduled, with experts presenting the latest advancements in specific clinical specialties, including multi-omics, genetics, and stem cells. Medlab Middle East also hosted a range of dedicated online focus days until July 22 to allow participants to continue to do business as well as featured over 180 educational sessions to choose from. The online event platform for both Arab Health and Medlab Middle East was launched on 23 May and will remain available until 22 July.
Latest MEDLAB 2021 News
- Ortho Exhibits VITROS Range of Diagnostic Testing and Automation Solutions at MEDLAB Middle East 2021
- MP Biomedicals Exhibits Diagnostics Kits and Sample Prep Solutions at MEDLAB Middle East 2021
- BD Demonstrates Latest Medtech Innovations at MEDLAB Middle East 2021
- Diagnostica Stago Highlights Max Generation Family of Coagulation Analyzers at MEDLAB Middle East 2021
- Randox Showcases Latest Product Portfolio and Services at MEDLAB Middle East 2021
- Horiba Medical Exhibits New Generation of Automated Hematology Analyzers at MEDLAB Middle East 2021
- Rad Source Technologies Introduces Premier X-Ray Blood Irradiator RS 3400 at MEDLAB Middle East 2021
- Nova Biomedical Showcases Advanced Point-of-Care Capillary Blood Analyzers at MEDLAB Middle East 2021
- Erba Mannheim Showcases Exciting New Introductions at MEDLAB Middle East 2021
- Bioperfectus Presents Advanced Infectious Disease Diagnostic Solutions at MEDLAB Middle East 2021
- PerkinElmer Demonstrates High-Throughput MSMS Dried Blood Spot Screening Solutions at Medlab Middle East 2021
- PerkinElmer’s EUROIMMUN Presents Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics
- LumiraDx Highlights Next-Generation Point of Care Solutions at MEDLAB Middle East Virtual Event
- Quidel Showcases Comprehensive Suite of COVID-19 Testing Solutions at MEDLAB Middle East 2021
Channels
Clinical Chemistry
view channel
Simple Oral Swab Monitors Persistent Inflammation in Primary Ciliary Dyskinesia
Primary ciliary dyskinesia is a rare lung disease that affects about one in 7,500 to 10,000 live births worldwide. Symptoms can begin in the newborn period and progress to recurrent respiratory infections... Read more
Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features
Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read moreMolecular Diagnostics
view channel
Noninvasive Sequencing Test Approaches Invasive Genome Sequencing for Prenatal Screening
Prenatal genetic evaluation guides obstetric care, but standard diagnostics often require invasive procedures that carry risks, stress, and access barriers. Noninvasive prenatal testing (NIPT) has expanded... Read more
Blood-Based Assay Detects HER2 Mutations to Guide NSCLC Treatment
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, and a subset of patients harbor HER2 (ERBB2) mutations that may be addressed with precision therapies. These HER2‑mutant tumors... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE
Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more
New Protein Targets Support Diagnostics for Louse-Borne Relapsing Fever
Louse-borne relapsing fever is a neglected infection caused by Borrelia recurrentis and spread by body lice, with untreated mortality reaching up to 20%. Recurrent febrile episodes complicate recognition... Read more
TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
Congenital TORCH infections can be asymptomatic during pregnancy yet cause stillbirth, birth defects, and lifelong disability in infants. Many regions still lack robust surveillance to guide testing and... Read more
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read morePathology
view channel
Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer
Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
AI Tool Speeds Brain Tumor Classification from Routine Histology Slides
Accurate classification of brain and spinal cord tumors increasingly depends on molecular profiling alongside histology, but access to such testing remains limited and results can take about two weeks.... Read more
IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy
Deficient DNA mismatch repair is an established predictive biomarker for response to immune checkpoint inhibitors, yet access to standardized assessment has varied across tumor types. Cancer remains the... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Open-Source Consortium Aims to Standardize Digital Pathology Workflows
Digital pathology is expanding rapidly as laboratories adopt whole-slide imaging and computational tools to meet growing diagnostic and biomarker-testing demand. However, fragmented software infrastructure... Read more









